Monte Rosa Therapeutics
GLUE
GLUE
115 hedge funds and large institutions have $281M invested in Monte Rosa Therapeutics in 2025 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 50 increasing their positions, 17 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
115
Holders Change
+10
Holders Change %
+9.52%
% of All Funds
1.54%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
27
Increased
50
Reduced
17
Closed
17
Calls
$483K
Puts
$30K
Net Calls
+$453K
Net Calls Change
+$246K
Top Buyers
1 |
SCM
Suvretta Capital Management
New York
|
$15.2M |
2 |
AQR Capital Management
Greenwich,
Connecticut
|
$5.79M |
3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
$2.12M |
4 |
Renaissance Technologies
New York
|
$2.77M |
5 |
Northern Trust
Chicago,
Illinois
|
$3.43M |